Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Mar 2025 for GlucoTrack, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
John Ballantyne: trading record in brief
John Ballantyne is a declared insider of GlucoTrack, Inc., with filings sourced from SEC (Form 4). Between 14 November 2024 and 26 March 2025, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 31 March 2025, reports a share grant in GlucoTrack, Inc. The median gap between a trade and its publication by SEC (Form 4) is 19 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Ballantyne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,560,553 shares0Common Stock, par value $0.001 per shareSEC:0001474506-25-000072:1
4,126 shares0Common Stock, par value $0.001 per shareSEC:0001474506-25-000072:2
132,036 shares@ €29.3446100.0% of flowCommon Stock, par value $0.001 per shareSEC:0001474506-25-000072:0
3 of 3 declarations
